Home/ Stocks/ NAGE

Niagen Bioscience, Inc. Common Stock

NAGE XNAS

$3.12 +0.06 (+1.97%) ▲ 15-min delayed

Open

$3.07

High

$3.13

Low

$2.95

Volume

890.0K

Market Cap

$240.54M

About Niagen Bioscience, Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Sector: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS Employees: 117 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$29.79M	$963.0K	$0.01
Q1 2026	$31.47M	$6.32M	$0.08
FY 2025	$129.42M	$17.38M	$0.22
Q3 2025	$33.99M	$4.58M	$0.06

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for NAGE yet. Check out our latest market news or earnings calendar.

Get NAGE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Niagen Bioscience, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.